// App-Quantinova.ai

670 : Correlation of durability of response with best response or early discontinuation: a post hoc analysis of the GARNET endometrial cancer cohorts

Researchers

Presenter

  • Lucy Gilbert

Principal Investigators

  • Kathleen Moore

  • Vanessa Samouelian

  • Cara Mathews

  • Maria-Pilar Barretina-Ginesta

  • Janet Rader

  • Anna Tinker

  • Adriano Gravina

  • Joanna Pikiel

  • Grace Antony

  • Eleftherios Zografos

  • Jennifer Veneris

  • Ana Oaknin

Medical Centers

  • Regional Center of Oncology, Gdansk, Gdansk, Poland

  • University of Oklahoma, Oklahoma City, OK

  • Women and Infants Hospital of RI, Providence, RI, USA

  • The University of British Columbia, Vancouver, BC, Canada

  • McGill University Health Centre, Montreal, QC, Canada

  • The Medical College of Wisconsin, Milwaukee, WI

  • Hospital Universitari Vall -Hebron. Ciberehd., Barcelona, Spain

  • GSK, Hertfordshire, UK

  • Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy

  • Medical School University of Girona, Girona, Spain

  • Centre hospitalier de l’Université de Montréal, Montréal, ON, Canada

Locations

  • Poland

  • Canada

  • Italy

  • United States

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

Biomarkers

  • Cluster of Differentiation 206

  • Microsatellite instability-high

Drug/Treatment

  • Dostarlimab

Outcome

  • N/A

Study Design

  • Open Label

  • Single Arm

  • Multicenteric

  • Cohort

Phase

  • I

Study Id's

  • NCT02715284

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved